Autopsy report · NCT03149120

Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas

“No patient enrolled as new similar study will be in system within 3 months”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

NYU Langone Health

Sponsor type

University, hospital or other

Conditions

Soft Tissue Sarcomas

Interventions

Nivolumab; Pazopanib

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Use of Hand Prosthesis With Direct Nerve Stimulation for Treatment of Phantom Limb Pain
  “Study has been completed in terms of duration but no patient has been recruited during this time” (79% match in meaning)
• Cannabinoids in Bipolar Affective Disorder
  “study was never started and no patients were ever enrolled” (76% match in meaning)
• Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)
  “No patient enrolled after 6 months from the start. The decision to withdraw the study was based on a feasibility reevaluation conducted with investigators.” (73% match in meaning)
• RCT Between UPP and Controls in Adult OSA
  “No patients have been enrolled, and will not. The study was never started” (72% match in meaning)
• Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
  “No patient enter this study.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.